Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.68 USD | -7.59% | -5.96% | -7.27% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.27% | 25.19M | |
+26.47% | 664B | |
+28.22% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.62% | 234B | |
+4.93% | 199B | |
-10.14% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Aker BioMarine Gains Krill Assets from Acasti Pharma in $3.1 Million Settlement Deal